Peripheral Arterial Disease: A Review of Disease Awareness and Management
References (98)
- et al.
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study
Lancet
(1992) - et al.
- et al.
Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
J Vasc Surg.
(1998) - et al.
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
Am J Med.
(2000) - et al.
Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal study
J Am Coll Cardiol.
(1984) Pentoxifylline: Its influence on the interaction of blood cells with the vessel wall
Atherosclerosis
(1997)- et al.
Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients
Am Heart J.
(1982) - et al.
Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein
Eur J Intern Med.
(2001) - et al.
Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment
Am J Cardiol.
(2003) - et al.
Statin use and functional decline in patients with and without peripheral arterial disease
J Ant Coll Cardiol.
(2006)
Influence of smoking on incidence and prevalence of peripheral arterial disease
J Vase Surg.
(2004)
Cigarette smoking as a risk factor for stroke. The Framingham Study
JAMA
(1988)
Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication
J Cardiorasc Pbarmacol.
(1982)
Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease
J Vasc Surg.
(2003)
Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication (Cochrane Review)
Cochrane Database Syst Rev.
(2001)
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin 12 analogue: A double-bfinded, randomized, controlled trial
J Am Coll Cardiol.
(2003)
Effect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study
Circulation
(1993)
Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: A call to action
Arch Intern Med.
(2003)
The prevalence of peripheral arterial disease in a defined population
Circulation
(1985)
American Heart Association. Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
Circulation
(2004)
Inflammation in atherosclerosis
Nature
(2002)
Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology
Circulation
(2004)
The L-arginine-nitric oxide pathway
N Engl J Med.
(1993)
Properties and mechanisms of production and action of endothelium-derived relaxing factor
J Cardiovasc Pharmacol.
(1986)
Nitric oxide insufficiency, platelet activation, and arterial thrombosis
Circ Res.
(2001)
Role of oxidative modifications in atherosclerosis
Physiol Rev.
(2004)
Disease of peripheral vessels
Peripheral arterial disease—epidemiological aspects
Vase Med.
(2001)
Clinical significance, detection and medical treatment for peripheral arterial disease
J Cardiopulrn Rebabil.
(2002)
Mortality over a period of 10 years in patients with peripheral arterial disease
N Engl J Med.
(1992)
Peripheral arterial disease: Insights from population studies of older adults
J Am Geriatr Soc.
(2000)
Peripheral arterial disease detection, awareness, and treatment in primary care
JAMA
(2001)
Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice
J Gen Intern Med.
(2001)
The ankle brachial index is associated with leg function and physical activity: The Walking and Leg Circulation Study
Ann Intern Med.
(2002)
The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing
Vase Med.
(1996)
The anklebrachial index in the elderly and risk of stroke, coronary disease, and death: The Framingham Study
Arch Intern Med.
(2003)
Relationship of high and low ankle brachial index to allcause and cardiovascular disease mortality: The Strong Heart Study
Circulation
(2004)
ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery
Peripheral arterial disease in people with diabetes
Diabetes Care.
(2003)
Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease
Arch Intern Med.
(1999)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
BMJ
(2002)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
Lancet
(1996)
A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly
Angiology
(1997)
Double-blind study of the effect of dipyridamole in patients with intermittent claudication [in German]
Vasa
(1992)
Controlled trial of high- versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease
Clin Inroestig
(1994)
Prevention of myocardial infarction and stroke in patients with intermittent claudication: Effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study
J Intern Med.
(1990)
Multicenter double-blind study of ticlopidine in the treatment of intermittent claudication and the prevention of its complications
Angiology
(1988)
Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs?
Thromb Haemost
(1989)
Cited by (32)
Effects of intermittent claudication due to arterial disease on pain-free gait
2021, Clinical BiomechanicsCitation Excerpt :Peripheral arterial disease affects 202 million people worldwide (Song et al., 2019); 20 million people in Europe, 8–10 million in north America, 10% of individuals over 65 years of age and 20% of those over 80 (Watson et al., 2006).
Peripheral Arterial Disease
2018, Heart Lung and CirculationTreatment of Superficial Femoral Artery Restenosis
2017, Journal of Vascular and Interventional RadiologyCOPART Risk Score Predicts Long-term Mortality in Peripheral Arterial Occlusive Disease
2015, European Journal of Vascular and Endovascular SurgeryCitation Excerpt :Supervised exercise could also achieve a further reduction of mortality, particularly in the HR group, as claudicants would be the ideal cohort for this type of therapy.26 Providing the calculated prognosis in the discharge letter after the first endovascular recanalization might help to minimise poor management of CV risk factors in PAOD patients by primary care physicians.27–30 Furthermore, closer control of coexistent CAD or cerebrovascular disease would help to achieve a reduction of mortality.
Copyright © 2006 Published by Elsevier Inc.